Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
29.09.25
/
50%
€37.40
Target price
29.09.26
€65.69
Performance (%)
-12.54%
Price
24.04.26
€32.71
Summary
This prediction is currently active. The price of Crinetics Pharmaceuticals Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.54%. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | -6.060% | -6.060% |
| iShares Core DAX® | -1.424% | 8.918% |
| iShares Nasdaq 100 | 3.274% | 16.275% |
| iShares Nikkei 225® | 1.745% | 16.239% |
| iShares S&P 500 | 1.447% | 10.913% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $65.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€39.40
06.01.26
06.01.26
€68.23
06.01.27
06.01.27
-16.98%
24.04.26
24.04.26
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25